the present invention relates to \u0434\u0435\u043f\u0440\u043e\u0442\u0435\u0438\u043d\u0438\u0437\u0438\u0440\u043e\u0432\u0430\u043d\u043d\u043e\u043c\u0443 substance from the blood of calves, for use in the prevention or treatment of \u043f\u043e\u0441\u0442\u0438\u043d\u0441\u0443\u043b\u044c\u0442\u043d\u044b\u0445 cognitive \u043d\u0430\u0440\u0443\u0448\u0435\u043d\u0438 hey, where \u0434\u0435\u043f\u0440\u043e\u0442\u0435\u0438\u043d\u0438\u0437\u0438\u0440\u043e\u0432\u0430\u043d\u043d\u044b\u0439 drug from the blood of calves is \u043f\u0430\u0440\u0435\u043d\u0442\u0435\u0440\u0430\u043b\u044c\u043d\u043e in 0 - 10 days after the onset of stroke at least once and for \u043f\u0430\u0440\u0435\u043d\u0442\u0435\u0440\u0430 \u043b\u044c\u043d\u044b\u043c introduction should be the period \u044d\u043d\u0442\u0435\u0440\u0430\u043b\u044c\u043d\u043e\u0433\u043e introduction.in the preferred version of the present invention \u0434\u0435\u043f\u0440\u043e\u0442\u0435\u0438\u043d\u0438\u0437\u0438\u0440\u043e\u0432\u0430\u043d\u043d\u044b\u0439 substance from the blood of calves injected intravenously after a \u0438\u043d\u0441\u0443\u043b\u044c the one time a day for no more than 20 days.the introduction of oral and intravenous should period of approximately 200 mg \u0434\u0435\u043f\u0440\u043e\u0442\u0435\u0438\u043d\u0438\u0437\u0438\u0440\u043e\u0432\u0430\u043d\u043d\u043e\u0433\u043e substance from the blood of calves, three times a day to loud and approximately 6 months or even longer, as in the continuous treatment. in the preferred version of the present invention \u0434\u0435\u043f\u0440\u043e\u0442\u0435\u0438\u043d\u0438\u0437\u0438\u0440\u043e\u0432\u0430\u043d\u043d\u044b\u0439 substance from the blood of calves is the essential means of \u0430\u043a\u0442\u043e\u0432\u0435\u0433\u0438\u043d\u00ae.Настоящее изобретение относится к депротеинизированному препарату из крови телят для применения в профилактике или лечении постинсультных когнитивных н
